CRYSTAL FORM OF FLUORINE-SUBSTITUTED INDAZOLE COMPOUND AND USE THEREOF

The present invention relates to a crystal form of a fluorine-substituted indazole compound and a use thereof. The present invention also relates to a pharmaceutical composition comprising the crystal form. Specifically, the crystal form or the pharmaceutical composition can be used for treating and...

Full description

Saved in:
Bibliographic Details
Main Authors ZUO, Yinglin, WANG, Xiaojun, SHAN, Yuefeng, CHEN, Liang
Format Patent
LanguageChinese
English
French
Published 27.06.2024
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present invention relates to a crystal form of a fluorine-substituted indazole compound and a use thereof. The present invention also relates to a pharmaceutical composition comprising the crystal form. Specifically, the crystal form or the pharmaceutical composition can be used for treating and preventing cardiovascular diseases or conditions. La présente invention concerne une forme cristalline d'un composé indazole substitué par du fluor et son utilisation. La présente invention concerne également une composition pharmaceutique comprenant la forme cristalline. Spécifiquement, la forme cristalline ou la composition pharmaceutique peut être utilisée pour traiter et prévenir des maladies ou des états cardiovasculaires. 本发明涉及氟取代的吲唑化合物的晶型及其用途。本发明还涉及包含所述晶型的药物组合物。具体地，所述晶型或所述药物组合物可用于治疗和预防心血管方面的疾病或病症。
Bibliography:Application Number: WO2023CN140301